Consumer Food Waste: Understanding Why Consumers Do Not Eat the Food They Acquire

One-third of all food suitable for human consumption is wasted or lost in the supply chain, causing substantial negative economic, social and environmental consequences. In developed countries, consumers are the single biggest producers of food waste. This dissertation aims to increase the theoretical understanding of the complex issue of consumer food waste. The fundamental research question concerns why consumers acquire food that they ultimately do not consume, but waste instead. Chapter 2 presents an extensive literature review of theoretical and empirical findings concerning consumer food waste and identifies promising future research directions. Chapters 3 and 4 draw on construal level theory and demonstrate that the temporal distance between a consumption decision (e.g., when making weekly food purchases in the grocery store) and the actual consumption moment (e.g., when preparing the meal) is critical in explaining why consumers acquire food that ends up being wasted. Chapter 4 further demonstrates that food is less likely to be wasted when consumers opt for more convenient food options—food options that require little time and effort to be prepared. Finally, Chapter 5 presents a general discussion of this research and its outcomes, explores both managerial and practical implications, and offers directions for future research. This dissertation provides new insights into the behavioral mechanisms underlying consumer food waste and directions on how to minimize food waste. Decreasing food waste is contingent on, for instance, the consumer’s ability to make realistic and smart decisions in the grocery store, and to stick to previously made consumption plans

Waste on Impulse? Food ordering, calorie intake and waste in out-of-home consumption

The fast-growing out-of-home consumption sector is responsible for monumental food waste. At the same time, this sector is transforming and increasingly introduces pre-ordering via smartphones and mobile devices to cater to consumers’ busy lifestyles. Drawing on construal level theory, we show in two behavioral studies that acquiring food for a distant consumption moment leads to more impulsive food acquisitions and higher calorie intake. Emphasizing the (un)healthiness of food by using traffic light labels does not dampen impulsive acquisitions at the point of sale, but does help consumers to consume fewer calories at the expense of wasting more food. Our findings introduce a dilemma for managers in the out-of-home consumption section. While making it easy for consumers to change or add to their order placed in advance boosts sales, this practice leads to more calories consumed and more waste.</p

The value of feed consumption data for breeding in laying hens

The results of statistical and experimental analyses of residual feed consumption (RFC) in White Leghorn laying hens are presented. RFC is defined as the difference between the observed feed consumption of a hen and its feed consumption predicted from its egg mass production, body weight gain and metabolic body weight. Variation in RFC was found to be related to differences in maintenance requirements in literature. High-low sampling studies with respect to RFC confirmed this, and showed that differences in physical activity, feather quality and basal matabolic rate were the most important variation sources. Optimum regression models were derived, and used to analyse RFC data statistically. Systematic and permanent phenotypic and additive genetic variation was found, confirming the findings of the experimental studies. The consequences for breeding for net feed efficiency are discussed

Active Surveillance for Prostate Cancer:Past, Current, and Future Trends

In response to the rising incidence of indolent, low-risk prostate cancer (PCa) due to increased prostate-specific antigen (PSA) screening in the 1990s, active surveillance (AS) emerged as a treatment modality to combat overtreatment by delaying or avoiding unnecessary definitive treatment and its associated morbidity. AS consists of regular monitoring of PSA levels, digital rectal exams, medical imaging, and prostate biopsies, so that definitive treatment is only offered when deemed necessary. This paper provides a narrative review of the evolution of AS since its inception and an overview of its current landscape and challenges. Although AS was initially only performed in a study setting, numerous studies have provided evidence for the safety and efficacy of AS which has led guidelines to recommend it as a treatment option for patients with low-risk PCa. For intermediate-risk disease, AS appears to be a viable option for those with favourable clinical characteristics. Over the years, the inclusion criteria, follow-up schedule and triggers for definitive treatment have evolved based on the results of various large AS cohorts. Given the burdensome nature of repeat biopsies, risk-based dynamic monitoring may further reduce overtreatment by avoiding repeat biopsies in selected patients.</p

What is the effect of MRI with targeted biopsies on the rate of patients discontinuing active surveillance? A reflection of the use of MRI in the PRIAS study

Background The reduction of overtreatment by active surveillance (AS) is limited in patients with low-risk prostate cancer (PCa) due to high rates of patients switching to radical treatment. MRI improves biopsy accuracy and could therewith affect inclusion in or continuation of AS. We aim to assess the effect of MRI with target biopsies on the total rate of patients discontinuing AS, and in particular discontinuation due to Grade Group (GG) reclassification. Methods Three subpopulations included in the prospective PRIAS study with GG 1 were studied. Group A consists of patients diagnosed before 2009 without MRI before or during AS. Group B consists of patients diagnosed without MRI, but all patients underwent MRI within 6 months after diagnosis. Group C consists of patients who underwent MRI before diagnosis and during follow-up. We used cumulative incidence curves to estimate the rates of discontinuation. Results In Group A (n = 500), the cumulative probability of discontinuing AS at 2 years is 27.5%; GG reclassification solely accounted for 6.9% of the discontinuation. In Group B (n = 351) these numbers are 30.9 and 22.8%, and for Group C (n = 435) 24.2 and 13.4%. The three groups were not randomized, however, baseline characteristics are highly comparable. Conclusions Performing an MRI before starting AS reduces the cumulative probability of discontinuing AS at 2 years. Performing an MRI after already being on AS increases the cumulative probability of discontinuing AS in comparison to not performing an MRI, especially because of an increase in GG reclassification. These results suggest that the use of MRI could lead to more patients being considered unsuitable for AS. Considering the excellent long-term cancer-specific survival of AS before the MRI era, the increased diagnostic accuracy of MRI could potentially lead to more overtreatment if definitions and treatment options of significant PCa are not adapted.Peer reviewe

Validation of the Dutch translation of the quality of recovery-15 scale

BACKGROUND: The 15-item Quality of Recovery-15 (QoR-15) scale is strongly recommended as a standard patient-reported outcome measure assessing the quality of recovery after surgery and anesthesia in the postoperative period. This study aimed to validate the Dutch translation of the questionnaire (QoR-15NL). MATERIALS AND METHODS: An observational, prospective, single-centre cohort study was conducted. Patients who underwent surgery under general anesthesia completed the QoR-15NL (preoperatively (t1) and twice postoperatively (t2 and t3)) and a visual analogue scale (VAS) for general recovery at t2. A psychometric evaluation was performed to assess the QoR-15NL's validity, reliability, responsiveness, reproducibility and feasibility. RESULTS: Two hundred and eleven patients agreed to participate (recruitment rate 94%), and 165 patients were included (completion rate 78%). The QoR-15NL score correlated with the VAS for general recovery (rs = 0.59). Construct validity was further demonstrated by confirmation of expected negative associations between the QoR-15NL and duration of surgery (rs = -0.25), duration of Post Anesthesia Care Unit stay (rs = -0.31), and duration of hospital stay (rs = -0.27). The QoR-15NL score decreased significantly according to the extent of surgery. Cronbach's alpha was 0.87, split-half reliability was 0.8, and the test-retest intra-class coefficient was 0.93. No significant floor- or ceiling effect was observed. CONCLUSION: The QoR-15NL scale is a valid, easy-to-use, and reliable outcome assessment tool with high responsiveness for patient-reported quality of recovery after surgery and general anesthesia in the Dutch-speaking population. The QoR-15NL's measurement properties are comparable to the original questionnaire and other translated versions. TRIAL REGISTRATION: not applicable

The measurement of membranous urethral length using transperineal ultrasound prior to radical prostatectomy

Objective: To compare preoperative membranous urethral length (MUL) measurements using magnetic resonance imaging (MRI) with two-dimensional transperineal ultrasound imaging (TPUS) in two supine positions on two separate days in men prior to radical prostatectomy. Materials and methods: MUL was prospectively measured in 18 male volunteers using MRI and on two separate occasions in two different patient positions using TPUS; the patient supine with the knees extended (Supine) and supine with the knees flexed to 70 degrees (Supine KF). Agreement between TPUS and MRI measurements of MUL was assessed using Bland-Altman method comparison techniques and a two-way mixed-effects single measures intraclass correlation (ICC). Test-retest reliability was assessed using a two-way random effects single measures ICC. Results: The mean difference in MUL measurements between MRI and i) TPUS Supine was -0.8 mm (95% limits of agreement (LOA): -3.2, 1.7) and ii) TPUS Supine KF was -0.8mm (95% LOA: -3.5, 1.9). ICC indicated a point estimate of excellent agreement between MRI and TPUS Supine ICC 0.93 (95% CI: 0.76, 0.98) and TPUS Supine KF ICC 0.91 (95 0 /0CI 0.79, 0.97). There was excellent agreement between TPUS Supine and TPUS Supine KF (ICC 0.98, 95% CI: 0.96, 0.99) with a mean difference of 0.3mm (95% LOA: -1.2 to 1.3mm). Conclusions: Preoperative MUL can be reliably measured using TPUS and demonstrates excellent agreement with MRI measurements of MUL. TPUS provides clinicians with an accessible non-invasive alternative to MRI for the measurement of MUL that can be used in outpatient urological settings and for patients where MRI is contraindicated